Aardark Therapeutics

Public

San Diego, CaliforniaBiotechhttps://www.aardvarktherapeutics.com

Aardark Therapeutics is now publicly traded

The data on this page reflects Aardark Therapeutics's private-market history up to the point it went public, including its funding rounds, valuation, and investors.

Last Round

Series C

May 9, 2024

Total Funding Raised

$129M

Company Overview

Aardvark Therapeutics is a biopharmaceutical company specializing in small molecule therapeutics aimed at treating obesity and rare genetic metabolic diseases.

Sector

Biotech

AI Layer

Non-AI

Keywords

bitter taste receptor (TAS2R) agonistoral gut-restricted small-molecule therapeutichyperphagia treatment for Prader-Willi Syndromesatiety hormone stimulation via gut-brain axissmall-molecule therapeutics for metabolic diseaseorphan disease drug developmenthypothalamic obesity treatmentfixed-dose combination drug for obesityGLP-1 and cholecystokinin (CCK) stimulationclinical-stage biopharmaceutical company

Aardark Therapeutics Comparables

Compare Aardark Therapeutics with similar companies based on industry and business-model similarity.

Aardark Therapeutics comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Kallyope	79%
ConSynance Therapeutics	76%
Aphaia Pharma	65%

View all Comparables

Aardark Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series C	May 9, 2024
Series B	Aug 5, 2021
Series A	Nov 29, 2019

View all Funding Rounds

Aardark Therapeutics Investors

Notable investors and investment history

Aardark Therapeutics investors
Investor	Rounds
BNH INVESTMENT	Series B, Series A
SymBiosis Capital Management	Series C
Foundation for Prader-Willi Research	Series C, Series B
Premier Partners	Series B, Series A
LG Technology Ventures	Series C
Cormorant Capital	Series C
Cantor Ventures	Series C

View all Investors

Aardark Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Aardark Therapeutics Filings

SEC and related filings with document metadata.

Firmographic Details

HeadquartersSan Diego, California

Employee Range34

Year Founded2017

Last FundingMay 9, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?